Related Experiment Videos
[Bile acids in coronary arteriosclerosis]
Kardiologiia
|October 1, 1984
Summary
Patients with atherosclerotic coronary heart disease often have type II hyperlipoproteinemia. Their blood serum bile acid levels were lower than in the control group.
Area of Science:
- Cardiology
- Biochemistry
- Lipidology
Context:
- Chronic coronary heart disease (CHD) is a significant health concern.
- Atherosclerosis is a primary cause of CHD.
- Hyperlipoproteinemia is a common comorbidity in CHD patients.
Purpose:
- To investigate the prevalence of hyperlipoproteinemia phenotypes in patients with atherosclerotic coronary heart disease.
- To analyze blood serum levels of lipids and bile acids in these patients.
- To compare these levels with a control group.
Summary:
- This study examined 76 patients with atherosclerotic coronary heart disease.
- Type II hyperlipoproteinemia was the most frequent phenotype (65.8%).
- Patients showed reduced blood serum bile acid levels compared to controls.
Impact:
- Findings highlight the commonality of type II hyperlipoproteinemia in atherosclerotic CHD.
- Lower bile acid levels may indicate a specific metabolic alteration in these patients.
- This research contributes to understanding lipid metabolism in coronary heart disease.